The U.S. Food and Drug Administration (FDA) has granted a regenerative medicine advanced therapy designation to MB-105, a CD5 ...
Reached agreement with FDA on pivotal study design for TSC-101 following productive end of Phase 1 meetingData from ALLOHA™ Phase 1 heme trial to ...
News Medical on MSN
Development of therapeutic cancer vaccines based on cancer immunity cycle
Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in ...
The programme focuses on CAR-T cell therapy, bridging the gap between research and clinical application while building India’s skilled talent base in advanced therapies.
LYL273 was granted Fast Track designation for the treatment of mCRC by the U.S. Food and Drug Administration. The Phase 1 clinical trial is continuing to enroll patients with refractory mCRC to ...
Our Bureau, Bengaluru Wednesday, November 12, 2025, 14:40 Hrs [IST] ...
A new study shows, for the first time, that cow cells can naturally become immortal—continuing to divide indefinitely without ...
AnaptysBio plans to advance rosnilimab for RA, with a program update expected in the first half of 2026. Read why ANAB stock ...
Finance Income, net, was $0.1 million for the three months ended September 30, 2025, compared to $1.5 million in the same ...
SOMERSET, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a U.S.-based global leader in cell therapy, today announced the official opening and ...
On November 7, Jiahui International Cancer Center (JICC) successfully treated a 78-year-old patient from New Zealand with ...
At 10 one-millionths of a meter wide, a single human cell is tiny. But something even smaller exerts an enormous influence on everything a cell does: proton concentration, or pH. On the microscopic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback